Allscripts Healthcare Solutions (Nasdaq: MDRX ) reported earnings on May 9. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Allscripts Healthcare Solutions missed estimates on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue dropped. Non-GAAP earnings per share shrank significantly. GAAP earnings per share shrank to a loss.
Gross margins expanded, operating margins shrank, net margins shrank.
Allscripts Healthcare Solutions reported revenue of $347.1 million. The 18 analysts polled by S&P Capital IQ hoped for net sales of $367.5 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.09. The 20 earnings estimates compiled by S&P Capital IQ predicted $0.14 per share. Non-GAAP EPS of $0.09 for Q1 were 25% lower than the prior-year quarter's $0.12 per share. GAAP EPS were -$0.07 for Q1 compared to $0.03 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 44.4%, 170 basis points better than the prior-year quarter. Operating margin was -8.2%, much worse than the prior-year quarter. Net margin was -3.3%, 490 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $371.2 million. On the bottom line, the average EPS estimate is $0.15.
Next year's average estimate for revenue is $1.49 billion. The average EPS estimate is $0.65.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 432 members out of 461 rating the stock outperform, and 29 members rating it underperform. Among 117 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 110 give Allscripts Healthcare Solutions a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Allscripts Healthcare Solutions is hold, with an average price target of $13.08.
Is Allscripts Healthcare Solutions the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Allscripts Healthcare Solutions to My Watchlist.